Evidence map›Paper›PMID 35883921›Full record

ArticleChildren (Basel, Switzerland)2022

Proactive and Reactive Recruitment of Black and Latino Adolescents in a Vaping Prevention Randomized Controlled Trial.

Francisco Cartujano-Barrera, Ruthmarie Hernández-Torres, Rafael H Orfin, Arlette Chávez-Iñiguez, Olga Alvarez Lopez, Chiamaka Azogini, Diana Bermudez, Evelyn Arana-Chicas, Xueya Cai, Scott McIntosh and 2 more

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Francisco Cartujano-BarreraDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-8069-1750
Ruthmarie Hernández-TorresDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.
Rafael H OrfinDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.
Arlette Chávez-IñiguezDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.
Olga Alvarez LopezDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.
Chiamaka AzoginiDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.
Diana BermudezHackensack High School, Hackensack Public Schools, Hackensack, NJ 07601, USA.
Evelyn Arana-ChicasDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.
Xueya CaiDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-7922-2703
Scott McIntoshDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-5776-9617
Deborah J OssipDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.
Ana Paula CupertinoDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-7594-969X

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR002001 · NCATS · UNIVERSITY OF ROCHESTER · PI WILSON, KAREN M., ZAND, MARTIN S · 2016 to 2024
$34.6M
WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI SUNDAR, ISAAC KIRUBAKARAN · 2018 to 2022
$19.8M
NRSA Training CoreTL1TR002000 · NCATS · UNIVERSITY OF ROCHESTER · PI THAKAR, JUILEE, VAN WIJNGAARDEN, EDWIN · 2016 to 2024
$4.1M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
NCATS NIH HHS UL1 TR002001NCI NIH HHS U54 CA228110NCI NIH HHS U54CA228110
6 · The paper itself

Abstract

The purpose of this study was to assesses the effectiveness of proactive and reactive methods in the recruitment of Black and Latino adolescents into a vaping-prevention randomized controlled trial (RCT). This study also assessed the characteristics of study participants by recruitment method. Proactive recruitment strategies included study presentations at community-based events (e.g., festivals, health fairs), school-based events (e.g., back-to-school events, after-school programs), and recreational centers (e.g., fitness centers, malls). Reactive recruitment strategies included study advertisements via social media (e.g., Facebook posts shared by local community-based organizations), word of mouth, and an academic-based research hub. Using proactive and reactive methods, in a 4-month period, 362 Black and Latino adolescents were successfully enrolled into the RCT. Compared to the proactive method, adolescents screened reactively were equally likely to be eligible but significantly more likely to enroll in the study. However, both proactive and reactive strategies made notable contributions to the overall recruitment effort. Moreover, proactive and reactive methods attracted adolescents with different characteristics (e.g., age, gender, sexual orientation, etc.). These findings suggest that both proactive and reactive recruitment strategies should be implemented for studies interested in recruiting a diverse sample of Black and Latino adolescents.

Indexed as

adolescenceBlacksLatinosrecruitmenttobacco controlvaping

Identifiers

PMID35883921
PMCPMC9321256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.